- Biomedical Science building, Room A-207, A-208
- Sang-hoon Cha, Ph.D.
Our main research area is to develop therapeutic antibody drug candidate for cancer, incurable immune disease by using hierachial antibody library systems and to create high affinity antibody for their target through affinity maturation. We are especially interested in creating bi-functional antibody fragment-effector fusion proteins for long-acting biotherapeutics.
Major research areas
- Development of therapeutic antibody drug candidate by using Hierachial antibody library systems.
- Development of high affinity antibody through affinity maturation.
- Utilization of an Anti-serum Albumin Fab Antibody for the development of Long-acting biotherapeutics.